Try our beta test site

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) (ORBIT-AF II)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Janssen Scientific Affairs, LLC
Sponsor:
Collaborators:
Duke Clinical Research Institute
Bayer
Information provided by (Responsible Party):
Janssen Scientific Affairs, LLC
ClinicalTrials.gov Identifier:
NCT01701817
First received: October 3, 2012
Last updated: February 22, 2017
Last verified: February 2017